Cargando…
Analysis of the lower incidence of medullary thyroid cancer in China
Autores principales: | Huang, Min, Fanciulli, Giuseppe, Wu, Shu-Qiong, Zhang, Zheng, Zhang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831069/ https://www.ncbi.nlm.nih.gov/pubmed/31634241 http://dx.doi.org/10.1097/CM9.0000000000000463 |
Ejemplares similares
-
Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?
por: Di Molfetta, Sergio, et al.
Publicado: (2021) -
Advances in the Management of Medullary Thyroid Carcinoma: Focus on Peptide Receptor Radionuclide Therapy
por: Grossrubatscher, Erika, et al.
Publicado: (2020) -
Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials?
por: Fanciulli, Giuseppe, et al.
Publicado: (2023) -
Activity of roniciclib in medullary thyroid cancer
por: Lin, Shu-Fu, et al.
Publicado: (2018) -
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value
por: Citarella, Anna, et al.
Publicado: (2023)